PF-3758309
PF-3758309 is an experimental anticancer drug which acts as an inhibitor of p21-activated kinases with highest affinity for PAK4.
≈ 1 min read
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
PF-3758309 is an experimental anticancer drug which acts as an inhibitor of p21-activated kinases with highest affinity for PAK4. It shows activity against a variety of different cancer types including colon, lung and pancreatic cancers, and is in early stage clinical trials.
Text derived from https://en.wikipedia.org/w/index.php?oldid=1330450308 under CC BY-SA 4.0; modifications have been made.